Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,336.50 Consensus Target Price from Analysts

Mettler-Toledo International, Inc. (NYSE:MTD) has been assigned a consensus recommendation of “Hold” from the twelve ratings firms that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $1,336.50.

Several research firms have recently weighed in on MTD. Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Barclays lifted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Bank of America lifted their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Citigroup boosted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th.

Mettler-Toledo International Trading Down 0.6%

Shares of MTD opened at $1,351.15 on Friday. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,438.46. The stock has a market cap of $27.83 billion, a P/E ratio of 34.21, a price-to-earnings-growth ratio of 4.05 and a beta of 1.37. The stock’s 50-day moving average price is $1,287.35 and its two-hundred day moving average price is $1,195.77.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analysts’ expectations of $957.41 million. During the same quarter in the previous year, the business posted $9.65 EPS. Mettler-Toledo International’s revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares of the company’s stock, valued at $123,012.16. The trade was a 63.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in MTD. GAMMA Investing LLC increased its position in Mettler-Toledo International by 1.6% during the 3rd quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock valued at $626,000 after buying an additional 8 shares in the last quarter. Greenleaf Trust increased its position in Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after buying an additional 10 shares in the last quarter. Brooklyn Investment Group increased its holdings in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 10 shares during the period. Sax Wealth Advisors LLC increased its holdings in shares of Mettler-Toledo International by 2.8% in the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock valued at $437,000 after purchasing an additional 10 shares during the period. Finally, Benjamin Edwards Inc. increased its holdings in shares of Mettler-Toledo International by 4.8% in the second quarter. Benjamin Edwards Inc. now owns 218 shares of the medical instruments supplier’s stock valued at $256,000 after purchasing an additional 10 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.